This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Fusion Pharmaceuticals Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Emily Capone: Innovator in Antibody Development
Introduction
Emily Capone is a distinguished inventor based in Cavallino, Italy. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies that target specific cell surface antigens associated with tumors. Her work is pivotal in advancing therapeutic options for cancer treatment.
Latest Patents
Emily Capone holds a patent for an "Endosialin-binding antibody." This invention relates to the generation of an antibody that specifically recognizes and binds Endosialin, a cell surface antigen characteristic of tumor pericytes and cells of tumor stroma. The antibody has the ability to become internalized in Endosialin-expressing cells and to block the activation of MAPK in PDGF-stimulated human pericytes. Additionally, the antibody can block angiogenesis induced by LGALS3BP, a known Endosialin interactor, and inhibit tumor growth both alone and in combination with a humanized antibody against LGALS3BP in human osteosarcoma xenografts. Furthermore, upon conjugation of the humanized version of the anti-Endosialin antibody with a duocarmycin derivative, the resulting antibody-drug conjugate displays potent and antigen-dependent in vitro tumor cell cytotoxicity and effective antitumor efficacy in vivo.
Career Highlights
Emily Capone is currently associated with Fusion Pharmaceuticals Inc., where she continues to push the boundaries of cancer research and treatment. Her innovative approach to antibody development has positioned her as a key figure in the biotechnology sector.
Collaborations
Emily collaborates with talented professionals in her field, including Annalisa Di Risio and Enza Piccolo. These collaborations enhance the research and development efforts at Fusion Pharmaceuticals Inc., fostering an environment of innovation and discovery.
Conclusion
Emily Capone's contributions to the field of antibody development exemplify the impact of innovative research on cancer treatment. Her work not only advances scientific knowledge but also holds the potential to improve patient outcomes in oncology.